Key statistics
On Wednesday, Kyverna Therapeutics Inc (KYTX:NSQ) closed at 7.55, 324.16% above the 52 week low of 1.78 set on Apr 17, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 7.87 |
|---|---|
| High | 8.10 |
| Low | 7.47 |
| Bid | 7.60 |
| Offer | 7.86 |
| Previous close | 7.85 |
| Average volume | 759.63k |
|---|---|
| Shares outstanding | 57.13m |
| Free float | 51.93m |
| P/E (TTM) | -- |
| Market cap | 448.45m USD |
| EPS (TTM) | -3.72 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
- Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer
- Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
- Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
- Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
- Kyverna Therapeutics Announces Proposed Public Offering of Common Stock
- Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
- Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
- Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
- Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
- Kyverna Therapeutics Secures up to $150 Million in Non-Dilutive Financing from Oxford Finance
More ▼
